Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes.
about
Dietary advice for treatment of type 2 diabetes mellitus in adultsMetabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetesInsulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in Spain: the ECOBIM study.Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical).Adiposity and fat distribution outcome measures: assessment and clinical implications.The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.Six-month Outcomes of Mobile Phone Application-based Self-management in a Patient with Type 2 Diabetes.Treating insulin resistance: future prospects.A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysisDiabetes medications and body weight.Therapeutic options that provide glycemic control and weight loss for patients with type 2 diabetes.Time perspective and weight management behaviors in newly diagnosed Type 2 diabetes: a mediational analysis.Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study.The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial.Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year.Efficacy and safety of the glucagon-like peptide-1 receptor agonist lixisenatide versus the dipeptidyl peptidase-4 inhibitor sitagliptin in young (<50 years) obese patients with type 2 diabetes mellitus.The Relationship between Diabetes Mellitus and Respiratory Function in Patients Eligible for Coronary Artery Bypass Grafting.
P2860
Q24243869-CE297A6D-6A10-47CD-ABD2-6AAEDEAE40BCQ33688563-BD27B208-275E-4882-A122-4A98B39FBAC0Q34344990-537BBECF-B4D9-4ACA-8303-2F6C88FFDF2AQ34728128-0837242D-E99C-49EE-9913-22F58E2FF791Q34982478-B339BC5A-71CD-4682-BB18-DA10902A48F2Q35006747-4D523F8C-74F9-476D-9A70-7ABED8EC6162Q35613084-EEC81819-18D7-406D-AEEA-A2C4AD91B293Q35916934-948AF385-3467-4BC5-B6C5-0CA97E8E0A1CQ36806514-5357A429-70FF-472C-B85F-0071CC20B9FBQ37435547-F0BBC027-D7C9-4E8D-A4BD-A4BCC3D04363Q37524006-A324DAFF-88C2-495B-9F80-68688E9C095FQ37682561-EC07CA58-7599-4D2F-B1DF-5BCA328BECD3Q39684381-B6A73B27-0B83-488B-8B0A-85E133B55D7FQ43143768-12605CA0-1606-4D4C-BB6C-06F6BA1EDA48Q44198041-650B9505-EB85-4E2C-9A54-FB97AB95AFFBQ44390409-7741B7AE-8573-4E0E-98A0-F484C7F37364Q47121902-D4C707B7-9375-48E8-8AC5-FC86479FDB09Q54938101-A60648E7-D37C-4299-BDFA-004D9DA02058
P2860
Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@ast
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@en
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@nl
type
label
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@ast
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@en
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@nl
prefLabel
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@ast
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@en
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@nl
P2860
P1476
Metabolic consequences of weig ...... lin action in type 2 diabetes.
@en
P2093
Williams KV
P2860
P304
P356
10.1046/J.1463-1326.2000.00049.X
P577
2000-06-01T00:00:00Z